UGANDA MALARIA SURVEILLANCE PROJECT Mulago Hospital Complex, P.O.Box 7475, Kampala, Tel , Fax ;

Similar documents
Building Capacity to Use Geospatial Technology for Development in Africa: Lessons from the Uganda GIS Project

Anti malarial prescription practices among children admitted to six public hospitals in Uganda from 2011 to 2013

Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs Last Updated: August, 2012

Module 5 Laboratory CONTENTS ILLUSTRATED GUIDES

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT

Meaningful Use Criteria for Eligible Hospitals and Eligible Professionals (EPs)

hospital s or CAH s inpatient or professional guidelines

Planning for Health Information Technology and Exchange in Public Health

Nige g ri e an a N at a ional a Antimal a ari a a Tre re t a men e t g ide d l e ines

Contact Information: West Texas Health Information Technology Regional Extension Center th Street MS 6232 Lubbock, Texas

EMR Name/ Model. meridianemr 4.2 CCHIT 2011 certified

CALL FOR LOAN APPLICATIONS

CPT only copyright 2014 American Medical Association. All rights reserved. 10/10/2014 Page 537 of 593

Achieving Meaningful Use

Use of Nucleic Acid Amplification Tests in TB patients in California

The EP/eligible hospital has enabled this functionality

Responsibilities of Public Health Departments to Control Tuberculosis

EMR Name/ Model. Cerner PowerChart Ambulatory (PowerWorks ASP)

InteliChart. Putting the Meaningful in Meaningful Use. Meeting current criteria while preparing for the future

The EP/eligible hospital has enabled this functionality. At least 80% of all unique patients. seen by the EP or admitted to the

RELEASE OF THE APPROVED LIST OF LOAN BENEFICIARIES 2015/16 ACADEMIC YEAR

54th ECSA Health Ministers Conference Mombasa, Kenya

HITECH Act Update: An Overview of the Medicare and Medicaid EHR Incentive Programs Regulations

Custom Report Data Elements: IT Database Fields. Source: American Hospital Association IT Survey

M&E Strategies for a Community IRS Program

Publication Year: 2013

DISEASE EARLY WARNING SYSTEM -Plus (DEWS-Plus) Weekly Epidemiological Report 33

1a-b. Title: Clinical Decision Support Helps Memorial Healthcare System Achieve 97 Percent Compliance With Pediatric Asthma Core Quality Measures

2. Is the data entered: Manually (i.e. by user) Automatically (i.e. by the ST product) Both

Medical Education in the United States, in the United Kingdom and in Japan. Nayuta Saito. The Jikei University School of Medicine. Anes 140.

cambodia Maternal, Newborn AND Child Health and Nutrition

Research Paper 84. By Ibrahim Kasirye and Gemma Ahaibwe

HEALTH SPECIALIST VISITS (HSV) PROGRAMME. All Cook Islanders living healthier lives and achieving their aspirations

The EP/eligible hospital has enabled this functionality

Change is Coming in 2014! ICD-10 will replace ICD-9 for Diagnosis Coding

Stage 1 measures. The EP/eligible hospital has enabled this functionality

Stage 1 measures. The EP/eligible hospital has enabled this functionality

An Overview of Meaningful Use: FAQs

Service Availability and Readiness Assessment (SARA)

MINISTRY OF HEALTH. Uganda National Health Laboratory Services Policy

Facility information- Please provide accurate contact information for the facility and the contact person should DDM have additional questions.

HIT Incentives: Issues of Concern to Hospitals in the CMS Proposed Meaningful Use Rule

Appendix 6.2 Data Source Described in Detail Hospital Data Sets

The economic and social impact of the Institute for Animal Health s work on Bluetongue disease (BTV-8)

Dr. Calvin Wilson Associate Professor of Family Medicine University of Colorado National University of Rwanda

EHR Incentive Program Stage 3 Objectives & Measures Crosswalk of Stage 3 Proposed Objectives, Measures & Corresponding Stage 2 Measures

MALARIA STATUS IN TANZANIA MAINLAND: AN OVERVIEW NATIONAL MALARIA FORUM- 25 TH APRIL 2014.

Measure Information Form

UGANDA HEALTH CARE SYSTEM

Environmental Health Science. Brian S. Schwartz, MD, MS

LINKING DEMOGRAPHIC SURVEILLANCE AND HEALTH SERVICE NEEDS

Childhood Tuberculosis Some Basic Issues. Jeffrey R. Starke, M.D. Baylor College of Medicine

Scottish Diabetes Survey

NEW ZEALAND INJURY PREVENTION STRATEGY SERIOUS INJURY OUTCOME INDICATORS

Health Information Exchange in NYS

The Importance of Understanding External Cause of Injury Codes

COURSE SYLLABUS. REQUIRED TEXTS: Gordis, L. Epidemiology. Philadelphia: W.B. Saunders Co., Available at UCSF Bookstore

MEANINGFUL USE STAGE 2 Summary of Proposed Rule (EP)

Prerequisite: HIM 101 with a minimum grade of C Knowledge of basic addition, subtraction, multiplication, and division facts are assumed.

The EP/eligible hospital has enabled this functionality

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT UPDATE

Approved: New Requirements for Residential and Outpatient Eating Disorders Programs

Chapter 8 Community Tuberculosis Control

Following Up with Patients Discharged from the Emergency Department: A Look at Voice and UCSF

Meaningful Use. Medicare and Medicaid EHR Incentive Programs

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

ALCOHOL RELATED DISORDERS Includes Alcohol Abuse and Alcohol Dependence; Does Not Include Alcohol Use Disorders

Appendix B: Provincial Case Definitions for Reportable Diseases

Enabling Patients Decision Making Power: A Meaningful Use Outcome. Lindsey Mongold, MHA HIT Practice Advisor Oklahoma Foundation for Medical Quality

TABLE 4: STAGE 2 MEANINGFUL USE OBJECTIVES AND ASSOCIATED MEASURES SORTED BY CORE AND MENU SET

Abstract. Introduction

Canada Health Infoway

ALCOHOL RELATED DISORDERS Includes Alcohol Abuse and Alcohol Dependence; Does Not Include Alcohol Use Disorders

WHO Informal Consultation on fever management in peripheral health care settings: a global review of evidence and practice

MEMORANDUM. Dr. Michael Lu, Associate Administrator Maternal and Child Health Bureau, Health Resources and Services Administration

Portugal s Northern Region Population Health Plan

Health Information Technology and the National Quality Agenda. Daphne Ayn Bascom, MD PhD Chief Clinical Systems Officer Medical Operations

Other Causes of Fever

CEM Clinical Audits 2013

REACHING ZERO DEFECTS IN CORE MEASURES. Mary Brady, RN, MS Ed, Senior Nursing Consultant, Healthcare Transformations LLC,

Access to Appropriate Services for High Risk. in New York State. New York State Department of Health

THE WESTERN AUSTRALIAN REVIEW OF DEATH POLICY 2013

Diabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council

Chapter 6 Case Ascertainment Methods

Custom Report Data Elements: 2012 IT Database Fields. Source: American Hospital Association IT Survey

The Centers for Medicare & Medicaid Services (CMS) seeks stakeholder comments on the following clinical quality measure under development:

Anthem Blue Cross Life and Health Insurance Company University of California San Francisco Custom Premier PPO 200/20 (200/20/80/60)

The rate of hospitalizations due to assaultive injuries by spouse or partner (E976.3) per 100,000 females (13 and over)

$0. See the chart starting on page 2 for your costs for services this plan covers.

U.S. President s Malaria Initiative (PMI) Approach to Health Systems Strengthening

How To Analyse The Causes Of Injury In A Health Care System

Reporting Period: For Stage 2, the reporting period must be the entire Federal Fiscal Year.

Uganda CO. El Nino, Cholera & Malaria Situation. 24,290 #of people affected by El Nino. 14,574 Children affected by El Nino (Uganda Red Cross Society)

Medicare & Medicaid EHR Incentive Programs

MEASURING PATIENT SATISFACTION IN UCMB HEALTH INSTITUTIONS

National Council for Higher Education. Higher Education Accredited Academic Programmes. June 2014

How To Improve Health Care Quality

Information Management

Overview of MU Stage 2 Joel White, Health IT Now

Implementing Community Based Maternal Death Reviews in Sierra Leone

Transcription:

UCSF UGANDA MALARIA SURVEILLANCE PROJECT Mulago Hospital Complex, P.O.Box 7475, Kampala, Tel. 041-530692, Fax 041-540524; e-mail mu-ucsf@infocom.co.ug Inpatient Surveillance Monthly Report September 2011 Introduction The Uganda Malaria Surveillance Project (UMSP) was formed in 2001 as a collaboration between researchers at the Makerere University-University of California San Francisco research collaboration and the Ministry of Health. Although Uganda s Health Management Information System (HMIS) remains the primary source of morbidity and mortality data, there are several limitations to this data. To address some of these limitations, UMSP started an inpatient health facility-based surveillance system in different epidemiological settings. The program began in 2010 with the goal of including 6 sentinel district hospitals by July 2011. The objective of this surveillance system is to provide accurate and timely data on morbidity and mortality patterns among hospitalized children at participating sites to help guide policy makers and other stakeholders. This monthly report is comprised of a table and graphs highlighting indicators of morbidity and mortality including treatment practices at participating sites for a specified month. The table below provides a summary of the total number of hospitalized children per site who fulfil each of the criteria for specified indicators. For each indicator a bar graph allowing for comparison of results across the sites is generated, each bar representative of the results (in proportions) for each site for that particular indicator. A list of definitions of terms used in the report and a table showing the numerators and denominator used to determine the indicators as proportions are included in the Appendix section (last page). Absolute numbers of children hospitalized Hospitalized children under 5 years of age only < 5 Any Clinical Lab Lab confirmed Site Total Any years lab diagnosis of confirmed complicated death test result Lab confirmed death with Tororo Hospital 263 237 232 114 108 82 12 4 Jinja Hospital 675 572 566 402 220 173 27 4 Kambuga Hospital 106 80 80 50 23 17 1 0 Mubende Hospital 142 122 119 66 38 31 15 2 Apac Hospital 90 61 60 35 33 16 2 2 Kabale Hospital 96 80 75 5 6 6 2 0

Data below only includes children under 5 years of age admitted to the hospital Proportion of patients with any diagnostic test result during hospitalization 10 97.9% 98.9% 100. 97.5% 98.4% 93.8% 8 6 4 Proportion of patients with clinical diagnosis of at discharge 10 8 6 48.1% 70.5% 62.5% 54.6% 57.4% 4 6.3% Proportion of patients with laboratory confirmed 10 8 6 4 46.6% 38.9% 28.8% 31.9% 55. 8.

Proportion of patients with laboratory confirmed complicated 10 8 6 4 35.3% 30.6% 21.3% 26.1% 26.7% 8. Proportion of patients who died from any cause during hospitalization 15% 12.3% 1 5% 5.1% 4.7% 3.3% 2.5% 1.3% Proportion of patients who died with laboratory confirmed during hospitalization 15% 1 5% 3.4% 1.7% 0.7% 0. 1.7% 0.

Antil treatment practices based on laboratory testing Any positive laboratory test result None IV Quinine Other antil 10 8 6 4 Only negative laboratory test results None IV Quinine Other antil 10 8 6 4 No laboratory test done None IV Quinine Other antil 10 8 6 Too few cases 4

Appendix I. Definitions Laboratory confirmed : Any hospitalized child with a positive test (thick blood smear or RDT) result Clinical diagnosis of : Any hospitalized child with a final discharge diagnosis of (confirmed or unconfirmed) as indicated by the clinician. Laboratory confirmed complicated : Any hospitalized child with a positive test result and fulfils any of the following: 1) any criteria for severe. 2) one or more general danger signs (vomiting everything, inability to drink, feed or breastfeed, lethargy or unconscious or convulsions) or 3) dies during hospitalization Indicators expressed as proportions Indicator with diagnostic test result with a clinical diagnosis of with laboratory confirmed children< 5 years of age with complicated who died of any cause who died with Antil treatment practices Definition Numerator: Number of hospitalized with a test result Denominator: Number of hospitalized Numerator: Number of hospitalized with a final diagnosis of Denominator: Number of hospitalized with any final diagnosis Numerator: Number of hospitalized with a positive lab test Denominator: Number of hospitalized with a test result Numerator: Number of hospitalized with + lab test and complicated Denominator: Number of hospitalized with a test result Numerator: Number of hospitalized who died of any cause Denominator: Number of hospitalized with a disposition Numerator: Number of hospitalized who died with a positive lab test Denominator: Number of hospitalized with a test result & disposition Numerator: Number in each treatment category stratified by test results Denominator: Totals for each test results strata